Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
09:57:17 EDT Mon 29 Apr 2024
Enter Symbol
or Name
USA
CA



News for U:PRGO from 2023-04-30 to 2024-04-29 - 28 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-25 06:00U:PRGONews ReleasePerrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to euros275 Million
2024-04-23 08:09U:PRGONews ReleasePerrigo to Release First Quarter 2024 Financial Results on May 7, 2024
2024-04-09 12:30U:PRGONews ReleaseOpill and WNBA Team Up for Groundbreaking Partnership
2024-03-04 08:00U:PRGONews ReleasePerrigo Commences Shipments of Opill(TM) to Retailers Nationwide, Empowering Millions to Enter a New Era of Reproductive Health Access in the United States
2024-02-29 16:21U:PRGONews ReleasePerrigo to Attend UBS Global Consumer and Retail Conference
2024-02-27 06:30U:PRGONews ReleasePerrigo Reports Fourth Quarter & Fiscal Year 2023 Financial Results From Continuing Operations; Launches Investment & Efficiency Program
2024-02-26 16:30U:PRGONews ReleasePerrigo Increases its Quarterly Dividend
2024-02-13 08:16U:PRGONews ReleasePerrigo to Release Fourth Quarter and Fiscal Year 2023 Financial Results on February 27, 2024
2023-11-29 08:54U:PRGONews ReleasePerrigo Announces Early Results of Cash Tender Offer for Notes
2023-11-10 09:16U:PRGONews ReleasePerrigo Announces Cash Tender Offer for Notes
2023-11-07 06:30U:PRGONews ReleasePerrigo Reports Third Quarter Fiscal Year 2023 Financial Results From Continuing Operations
2023-11-02 13:39U:PRGONews ReleasePerrigo Announces Quarterly Dividend
2023-10-31 08:54U:PRGONews ReleasePerrigo to Attend Upcoming Consumer Investor Conferences
2023-10-24 09:54U:PRGONews ReleasePerrigo to Release Third Quarter 2023 Financial Results on November 7, 2023
2023-09-11 16:05U:PRGONews ReleasePerrigo Announces Leadership Update
2023-08-24 09:41U:PRGONews ReleasePerrigo to Attend Upcoming Consumer Investor Conferences
2023-08-08 06:30U:PRGONews ReleasePerrigo Reports Second Quarter Fiscal Year 2023 Financial Results From Continuing Operations
2023-08-02 10:19U:PRGONews ReleasePERRIGO ANNOUNCES QUARTERLY DIVIDEND
2023-07-25 09:31U:PRGONews ReleasePerrigo to Release Second Quarter 2023 Financial Results and Present at an Industry Growth Conference
2023-07-13 08:38U:PRGONews ReleasePerrigo Announces U.S. FDA Approval for Opill ‚ ® OTC Daily Oral Contraceptive
2023-06-08 07:40U:PRGONews ReleasePerrigo Appoints Patrick Lockwood-Taylor as President and CEO
2023-05-24 09:09U:PRGONews ReleasePerrigo to Host 1x1 Investor Meetings at the 23rd Annual Oppenheimer Consumer Growth & E-Commerce Conference
2023-05-16 11:43U:PRGONews ReleaseCOUNTRY STAR MITCHELL TENPENNY AND PREVACID ANNOUNCE "BEAT THE BURN" - A LIVE TIK TOK CONCERT TO SING AWAY STRESS
2023-05-16 09:02U:PRGONews ReleasePERRIGO ANNOUNCES U.S. FDA APPROVAL FOR NICOTINE COATED MINT LOZENGE
2023-05-10 13:40U:PRGONews ReleaseFDA Joint Advisory Committee Votes in Favor of Perrigo's Opill ‚ ® Daily Oral Contraceptive for OTC Use
2023-05-09 06:32U:PRGONews ReleasePerrigo Reports First Quarter Fiscal Year 2023 Financial Results From Continuing Operations
2023-05-09 06:30U:PRGONews ReleasePerrigo Announces Chief Executive Officer Retirement and Succession Plan
2023-05-04 08:23U:PRGONews ReleasePERRIGO ANNOUNCES QUARTERLY DIVIDEND